Web Analytics

Investor Profile

Boehringer Ingelheim

Boehringer Ingelheim Germany - Ingelheim am Rhein, Rhineland-Palatinate
INVESTOR

1 Disclosed Funding Rounds $5,198,000
5 Participating Investments




Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates

Invested In

Company Date Round Raised
  C-mo Medical Solutions January, 31 ,2023 Seed $5,198,000
  DiogenX May, 11 ,2023 Series A $30,056,125
  Otto September, 01 ,2023 Series B $43,000,000
  Actym Therapeutics, Inc. October, 20 ,2023 Series A $59,500,000
  GLOX Therapeutics Ltd. November, 15 ,2023 Unknown $5,362,000